American Express Hit With 40% Profit Slump; Shares Fall 3.6%
NYC Hotel Occupancy Rate Crashes Toward 10% As Permanent Closures Loom
Sweden Refuses To Impose New Lockdown Measures, Saying People Have Suffered Enough
Weekly Market Review: Marking Time Ahead of Election
Illinois Tool Gains On 3Q Sales Beat; Analyst Sticks To Hold
What 'The Great Reset' Architects Don't Want You To Understand About Economics
24/10/20: America's Scariest Charts: Duration of Unemployment & Employment Index
Housing Market Goes Nuts, Everyone Sees It, But It Can't Last
Latino Business Owner: This Election Is Not About Donald Trump
Covid Scenarios For 2021
24/10/20: America's Scariest Charts: Non-farm Payrolls
24/10/20: U.S. Labor Force Participation Rate is Falling, Again
Stimulus. No Stimulus. Market Bounces With Headlines. 10-23-20
Recent College Grads Face Worst Employment Prospects In Decades Thanks To COVID-19
To Save The Stock Market, The Fed Threatens Destruction Of Trillions In Middle-Class Retirement
The Destruction Of The Euro
Inflationism Has Overturned Society
COVID-19 causes some patients' immune systems to attack their own bodies, which may contribute to severe illness
The Nasdaq (INDEXNASDAQ: .IXIC) short squeeze is over
Double-Dip Recession Imminent (Or Did The First One Ever End?)
Week Ahead – The final stretch
The great debate on value investing
US Manufacturing Disappoints In Early October PMI Data As Election Anxiety Builds
Business Round Table Must Help Ensure Free And Fair Elections
Global Markets Rise Despite Fading Odds Of Stimulus Deal
Blood of recovered Covid-19 patients shows little benefit as treatment
Gilead’s Remdesivir Wins FDA’s First COVID-19 Drug Approval
Shedlock: Unemployment Claims Drop For The Wrong Reason
Will The US Avoid Eurozone’s Rising Double-Dip Recession Risk?
Gilead’s remdesivir finally gets US approval